Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel

References

• CheethamPPetrylakDPTubulin-targeted agents including docetaxel and cabazitaxelCancer J2013191596523337758
   PubMed Web of Science ®Google Scholar
• van OosteromATSchrijversDSchriiversD corrected to Schrijvers DDocetaxel (Taxotere), a review of preclinical and clinical experience. Part II: clinical experienceAnticancer Drugs1995633563687670133
   PubMed Web of Science ®Google Scholar
• MarreFSanderinkGJde SousaGGaillardCMartinetMRahmaniRHepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humansCancer Res1996566129613028640817
   PubMed Web of Science ®Google Scholar
• BardelmeijerHAOuwehandMBuckleTLow systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavirCancer Res200262216158616412414642
   PubMed Web of Science ®Google Scholar
• HirthJWatkinsPBStrawdermanMSchottABakerLHThe effect of an individual’s cytochrome CYP3A4 activity on docetaxel clearanceClin Cancer Res2000641255125810778948
   PubMedGoogle Scholar
• PondGRArmstrongAJGalskyMDWoodBALeopoldLSonpavdeGEfficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trialsUrol Oncol20133181457146322552048
   PubMedGoogle Scholar
• HendrikxJJLagasJSSongJ-YYRitonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer modelInt J Cancer2016138375876926297509
   PubMed Web of Science ®Google Scholar
• HuismanMTSmitJWWiltshireHRBeijnenJHSchinkelAHAssessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavirJ Pharmacol Exp Ther2003304259660212538811
   PubMedGoogle Scholar
• TsoiKMMacParlandSAMaX-ZMechanism of hard-nanomaterial clearance by the liverNat Mater201615111212122127525571
   PubMed Web of Science ®Google Scholar
• BraetFWisseEStructural and functional aspects of liver sinusoidal endothelial cell fenestrae: a reviewComp Hepatol200211112437787
   PubMedGoogle Scholar
• HanleyMJCancalonPWidmerWWGreenblattDJThe effect of grapefruit juice on drug dispositionExpert Opin Drug Metab Toxicol20117326728621254874
   PubMed Web of Science ®Google Scholar
• ValenzuelaBRebolloJPérezTBrugarolasAPérez-RuixoJJEffect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case reportBr J Clin Pharmacol201172697898121692829
   PubMedGoogle Scholar
• BaileyDGMalcolmJArnoldOSpenceJDGrapefruit juice-drug interactionsBr J Clin Pharmacol19984621011109723817
   PubMed Web of Science ®Google Scholar
• FiskeCHSubbarowYThe colorimetric determination of phosphorusJ Biol Chem1925662375400
   Google Scholar
• ChenPSToribaraTYWarnerHMicrodetermination of phosphorusAnal Chem1956281117561758
   Web of Science ®Google Scholar
• ChangJPaillardAPassiraniCTransferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cellsPharm Res20122961495150522167349
   PubMed Web of Science ®Google Scholar
• HuZXiaXTangLProcess for synthesizing oil and surfactant-free hyaluronic acid nanoparticles and microparticles2009US Patent20060040892 A1
   Google Scholar
• DonatoMTJiménezNCastellJVGómez-LechónMJFluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymesDrug Metab Dispos200432769970615205384
   PubMed Web of Science ®Google Scholar
• PriceRJSurryDRenwickABMeneses-LorenteGLakeBGEvansDCCYP isoform induction screening in 96-well plates: use of 7-benzyloxy-4-trifluoromethylcoumarin as a substrate for studies with rat hepatocytesXenobiotica200030878179511037111
   PubMed Web of Science ®Google Scholar
• SeglenPOPreparation of isolated rat liver cellsMethods Cell Biol1976132983177845
   PubMedGoogle Scholar
• LiW-CRalphsKLToshDIsolation and culture of adult mouse hepatocytesMethods Mol Biol201063318519620204628
   PubMedGoogle Scholar
• LangdonSPHendriksHRBraakhuisB-JMPreclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyAnn Oncol1994554154228075048
   PubMedGoogle Scholar
• TrivediRKompellaUBNanomicellar formulations for sustained drug delivery: strategies and underlying principlesNanomedicine (Lond)20105348550520394539
   PubMed Web of Science ®Google Scholar
• ChouDKKrishnamurthyRRandolphTWCarpenterJFManningMCEffects of Tween 20 and Tween 80 on the stability of Albutropin during agitationJ Pharm Sci20059461368138115858848
   PubMed Web of Science ®Google Scholar
• BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
   PubMed Web of Science ®Google Scholar
• NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater20098754355719525947
   PubMed Web of Science ®Google Scholar
• KanebrattKPAnderssonTBEvaluation of HepaRG cells as an in vitro model for human drug metabolism studiesDrug Metab Dispos20083671444145218385292
   PubMed Web of Science ®Google Scholar
• AnthérieuSChesnéCLiRStable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cellsDrug Metab Dispos201038351652520019244
   PubMed Web of Science ®Google Scholar
• ReddyLHBazileDDrug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeuticsAdv Drug Deliv Rev201471345724184489
   PubMed Web of Science ®Google Scholar
• van TellingenOBeijnenJHVerweijJScherrenburgEJNooijenWJSparreboomARapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in miceClin Cancer Res19995102918292410537361
   PubMedGoogle Scholar
• Díaz-MoscosoASoft versus hard nanoparticles in the delivery of aromatic macrocycles for photodynamic therapy of cancerInt J Med Biomed Res2012111223
   Google Scholar
• KangJ-HToitaRMurataMLiver cell-targeted delivery of therapeutic moleculesCrit Rev Biotechnol201636113214325025274
   PubMed Web of Science ®Google Scholar
• D’SouzaAADevarajanPVAsialoglycoprotein receptor mediated hepatocyte targeting – strategies and applicationsJ Control Release201520312613925701309
   PubMed Web of Science ®Google Scholar
• ZhangYNPoonWTavaresAJMcGilvrayIDChanWCWNanoparticle-liver interactions: cellular uptake and hepatobiliary eliminationJ Control Release201624033234826774224
   PubMed Web of Science ®Google Scholar
• SalmasoSCalicetiPStealth properties to improve therapeutic efficacy of drug nanocarriersJ Drug Deliv2013201337425223533769
   PubMedGoogle Scholar
• HuC-MJFangRHLukBTZhangLPolymeric nanotherapeutics: clinical development and advances in stealth functionalization strategiesNanoscale201461657524280870
   PubMed Web of Science ®Google Scholar
• RennertKSteinbornSGrögerMA microfluidically perfused three dimensional human liver modelBiomaterials20157111913126322723
   PubMed Web of Science ®Google Scholar
• TangCPrueksaritanontTUse of in vivo animal models to assess pharmacokinetic drug-drug interactionsPharm Res20102791772178720428930
   PubMed Web of Science ®Google Scholar
• MartignoniMGroothuisGMde KanterRSpecies differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and inductionExpert Opin Drug Metab Toxicol20062687589417125407
   PubMed Web of Science ®Google Scholar
• RenaudHJCuiJYKhanMKlaassenCDTissue distribution and gender-divergent expression of 78 cytochrome p450 mRNAs in miceToxicol Sci2011124226127721920951
   PubMed Web of Science ®Google Scholar
• SarinHPhysiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJ Angiogenes Res20102111920150991
   PubMedGoogle Scholar
• ZhouSChanSYGohBCMechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsClin Pharmacokinet200544327930415762770
   PubMed Web of Science ®Google Scholar
• KōjiroMPathology of Hepatocellular CarcinomaMalden, MABlackwell Publishing2006
   Google Scholar
• TsunedomiRIizukaNHamamotoYPatterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinomaInt J Oncol200527366166716077914
   PubMed Web of Science ®Google Scholar
• SpratlinJSawyerMBPharmacogenetics of paclitaxel metabolismCrit Rev Oncol Hematol200761322222917092739
   PubMed Web of Science ®Google Scholar
• VenkatakrishnanKVon MoltkeLLGreenblattDJHuman drug metabolism and the cytochromes P450: application and relevance of in vitro modelsJ Clin Pharmacol200141111149117911697750
   PubMed Web of Science ®Google Scholar